Trametinib

Trametinib


Trametinib is an orally active diaryl-anilide that allosterically blocks mitogen-activated protein kinase kinase-1 and -2 at sub-nanomolar potency, inducing autophagy and apoptosis to curb proliferation in RAS/RAF-driven tumors.

Molecular structure of the compound BP-44059
    • Unit
    • Price
    • Qty
    • 250 MG
    • $130.00
    • 500 MG
    • $210.00
    • 1 G
    • $350.00

Usually ships within 24 hours.


Would you like to inquire about custom quantity?
Inquire